Toxic epidermal necrolyis after vancomycin use: A case report and discussion of management

American Journal of Therapeutics

Volumn 20, Issue 2, 2013, Pages 223-225

  Changela, Avani ^a   Javaiya, Hemangkumar ^a   Rickenback, Kiersten ^a   Elnawawi, Ashraf ^a   Changela, Kinesh ^a  

^a BROOKLYN HOSPITAL CENTER   (United States)

Author keywords

Apoptosis; Dermoepidermal junction; Toxic epidermal necrolysis; Vancomycin

Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN A; PREDNISONE; VANCOMYCIN;

ABSCESS; ABSCESS DRAINAGE; ADULT; AFRICAN AMERICAN; ANTIBIOTIC THERAPY; ARTICLE; BLISTER; BLOOD CULTURE; BODY SURFACE; CASE REPORT; CORTICOSTEROID THERAPY; DISEASE DURATION; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FACE; FEVER; FLUID THERAPY; FOLLOW UP; HOSPITAL DISCHARGE; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN BLOOD LEVEL; LEUKOCYTE COUNT; LOADING DRUG DOSE; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NEUTROPHIL COUNT; PATIENT TRANSPORT; PRIORITY JOURNAL; PURPURA; SKIN BIOPSY; SKIN CARE; STEVENS JOHNSON SYNDROME; THIGH; TOXIC EPIDERMAL NECROLYSIS; TREATMENT RESPONSE;

ABSCESS; ADULT; ANTI-BACTERIAL AGENTS; BACTEREMIA; EPIDERMAL NECROLYSIS, TOXIC; HUMANS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCAL INFECTIONS; VANCOMYCIN;

EID: 84875202569     PISSN: 10752765     EISSN: 15363686     Source Type: Journal    
DOI: 10.1097/MJT.0b013e3181f94c27     Document Type: Article

References (17)

1. Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N Engl J Med. 1994;331:1272-1285
2. Vidal C, Gonzá lez Quintela A, Fuente R. Toxic epidermal necrolysis due to vancomycin. Ann Allergy. 1992;68: 345-347
3. Klevens RM, Edwards JR, Tenover FC, et al. Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992-2003. Clin Infect Dis. 2006;42:389-391
4. Wolkenstein PC, Adle H, Wechsler J, et al. Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis. Br J Dermatol. 1996;134:710-714
5. Sherertz EF, Jegasothy BV, Lazarus GS. Phenytoin hypersensitivity reaction presenting with toxic epidermal necrolysis and severe hepatitis. Report of a patient treated with corticosteroid ''pulse therapy.'' J Am Acad Dermatol. 1985,12:178-181
6. Halebian PH, Corder VJ, Madden MR, et al. Improved burn center survival of patients with toxic epidermal necrolysis managed without corticosteroids. Ann Surg. 1986;204:503-512
7. Kelemen JJ, Cioffi WG, McManus WF, et al. Burn center care for patients with toxic epidermal necrolysis. J Am Coll Surg. 1995;180:273-278
8. Hewitt J, Ormerod AD. Toxic epidermal necrolysis treated with cyclosporin. Clin Exp Dermatol. 1992,17:264-265
9. Heng MC, Allen SG. Efficacy of cyclophosphamide in toxic epidermal necrolysis: Clinical and pathophysiologic aspects. J Am Acad Dermatol. 1991;25:778-786
10. Hewitt J, Ormerod AD. Toxic epidermal necrolysis treated with cyclosporin. Clin Exp Dermatol. 1992;17:264-265
11. Arevalo JM, Lorente JA, Gonzalez-Herrada C, et al. Treatment of toxic epidermal necrolysis with cyclosporin A. J Trauma. 2000;48:473-478
12. Trautmann A, Klein CE, Kampgen E, et al. Severe bullous drug reactions treated successfully with cyclophosphamide [letter]. Br J Dermatol. 1998;139:1127-1128
13. Kamanbroo D, Schmitz-Landgraf W, Czarnetski BM. Plasmapheresis in severe drug-induced toxic epidermal necrolysis. Arch Dermatol. 1985;121:1548-1549
14. Fischer M, Fiedler E, Marsch WC, et al. Antitumour necrosis factor-Antibodies (infliximab) in the treatment of a patient with toxic epidermal necrolysis. Br J Dermatol. 2002;146:707-708
15. Paquet P, Jacob E, Damas P, et al. Treatment of druginduced toxic epidermal necrolysis (Lyell's syndrome) with intravenous human immunoglobulins. Burns. 2001; 27:652-655
16. Viard I, Wehrli P, Bullani R, et al. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science. 1998;282: 490-493
17. Paquet P, Jacob E, Damas P, et al. Recurrent fatal drug induced toxic epidermal necrolysis (Lyell's syndrome) after putative b-lactam cross-reactivity: Case report and scrutiny of antibiotic imputability. Crit Care Med. 2002;30: 2580-2583